Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement

被引：31

作者：

Boursier, Jerome ^{[1
,2
]}

Anty, Rodolphe ^{[3
,4
,5
]}

Carette, Claire ^{[6
]}

Cariou, Bertrand ^{[7
]}

Castera, Laurent ^{[8
,9
]}

Caussy, Cyrielle ^{[10
,11
]}

Fontaine, Helene ^{[12
]}

Garioud, Armand ^{[13
]}

Gourdy, Pierre ^{[14
,15
]}

Guerci, Bruno ^{[16
,17
]}

Guillaume, Maeva ^{[18
,19
]}

Michot, Niasha ^{[20
]}

Minello, Anne ^{[21
]}

Ouizeman, Dann J. ^{[3
]}

Serfaty, Lawrence ^{[22
]}

Bonnet, Fabrice ^{[23
]}

Verges, Bruno ^{[24
,25
]}

Petit, Jean-Michel ^{[24
,25
]}

机构：

[1] Univ Angers, Lab HIFIH, Angers, France

[2] CHU Angers, Serv Hepatogastroenterol & Oncol Digest, Angers, France

[3] CHU Nice, Digest Ctr, Nice, France

[4] INSERM, U1065, Team Complicat Hepat Obesite 8, Nice, France

[5] Univ Cote Azur, Fac Med, Nice, France

[6] Univ Paris, Hop Europeen Georges Pompidou, AP HP Ctr, Serv Nutr,Ctr Specialise Obesite CSO Ile de Franc, Paris, France

[7] Univ Nantes, CHU Nantes, INSERM, CNRS,Inst Thorax, F-44000 Nantes, France

[8] Hop Beaujon, AP HP, Dept Hepatol, Clichy, France

[9] Univ Paris, INSERM UMR 1149, Ctr Rech Sur Inflammat Paris Montmartre, Clichy, France

[10] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM, INRA,INSA Lyon,CarMen Lab, F-69495 Pierre Benite, France

[11] Hosp Civils Lyon, Hop Lyon Sud, Dept Endocrinol Diabet & Nutr, F-69495 Pierre Benite, France

[12] Hop Cochin, AP HP, Unite Hepatol, Paris, France

[13] Ctr Hosp Intercommunal, GHT Confluences, ANGH, Serv Hepatogastroenterol, Villeneuve St Georges, France

[14] CHU Toulouse, Serv Diabetol Malad Metab & Nutr, Toulouse, France

[15] Univ Toulouse 3, INSERM UPS, UMR1297, Inst Malad Metab & Cardiovasc, Toulouse, France

[16] Hop Brabois, Dept Endocrinol Diabetol & Nutr, F-54500 Vandoeuvre Les Nancy, France

[17] Univ Lorraine, F-54500 Vandoeuvre Les Nancy, France

[18] Digest Ctr, Clin Pasteur, Toulouse, France

[19] INSERM, U1048, Equipe 9, Toulouse, France

[20] CHRU Nancy, Unite Assistance Nutr, Nancy, France

[21] Hop Univ Francois Mitterrand, Dept Gastroenterol & Hepatol, Dijon, France

[22] Hop Univ Strasbourg, Hop Hautepierre, Serv Hepatogastroenterol, Strasbourg, France

[23] Univ Rennes 1, CHU Rennes, Dept Endocrinol Diabetol & Nutr, Rennes, France

[24] Hop Univ Dijon, Dept Endocrinol Diabetol & Malad Metab, Dijon, France

[25] INSERM LNC UMR1231, Dijon, France

来源：

DIABETES & METABOLISM | 2021年 / 47卷 / 05期

关键词：

Cirrhosis; Diagnosis; Epidemiology; Monitoring; Pharmacological treatment; Type 2 diabetes mellitus; SINGLE-DOSE PHARMACOKINETICS; PLACEBO-CONTROLLED TRIAL; GLUCOSE-TOLERANCE TEST; CHRONIC LIVER-DISEASES; CLINICAL-IMPLICATIONS; HEPATIC IMPAIRMENT; GLYCATED HEMOGLOBIN; SAFETY PROFILE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA;

D O I：

10.1016/j.diabet.2021.101272

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes mellitus (T2DM) is a frequent comorbidity in patients with cirrhosis that is projected to rise in prevalence due to the worldwide burden of obesity, insulin-resistance and non-alcoholic fatty liver disease. The management of T2DM in patients with cirrhosis is complex given the requirement for accurate adaptation according to the level of liver function impairment, with lack of summary of the little evidence available in the literature. Here, we summarise the data available with respect to the epidemiology and the impact of T2DM in patients with cirrhosis, as well as those on the management of T2DM in these patients. We provide guidance for the diagnosis of T2DM and the monitoring of glycaemic control in patients with cirrhosis, and for the management of nutrition and pharmacological treatments in relation to the level of liver dysfunction. (C) 2021 Elsevier Masson SAS. All rights reserved.

引用

页数：14

共 50 条

[31] Position statement: Surgery and Diabetes mellitus
Fasching, Peter
Huber, Joakim
Clodi, Martin
Abrahamian, Heidemarie
Ludvik, Bernhard
WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 115 - 119
[32] STATEMENT ON HYPERTENSION IN DIABETES-MELLITUS
ROCCELLA, EJ
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (06) : 1165 - 1166
[33] Position statement: surgery and diabetes mellitus
Fasching, Peter
Huber, Joakim
Clodi, Martin
Abrahamian, Heidemarie
Ludvik, Bernhard
WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S179 - S183
[34] An International Position Statement on the Management of Frailty in Diabetes Mellitus: Summary of Recommendations 2017
Sinclair A.J.
Abdelhafiz A.
Dunning T.
Izquierdo M.
Rodriguez Manas L.
Bourdel-Marchasson I.
Morley J.E.
Munshi M.
Woo J.
Vellas B.
The Journal of Frailty & Aging, 2018, 7 (1) : 10 - 20
[35] Diabetes Mellitus and Pancreas: An Overview
Alizadeh, Amir Houshang Mohammad
JOURNAL OF THE PANCREAS, 2020, 21 (04): : 72 - 73
[36] Overview of childhood diabetes mellitus
Umar, U. I.
AFRICAN JOURNAL OF DIABETES MEDICINE, 2016, 24 (01): : 5 - 9
[37] Diagnosis and Management of Gestational Diabetes Mellitus: An Overview of National and International Guidelines
Tsakiridis, Ioannis
Giouleka, Sonia
Mamopoulos, Apostolos
Kourtis, Anargyros
Athanasiadis, Apostolos
Filopoulou, Dionysia
Dagklis, Themistoklis
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (06) : 367 - 381
[38] Overview of the Guidelines and Evidence for the Pharmacologic Management of Type 2 Diabetes Mellitus
Liday, Cara
PHARMACOTHERAPY, 2011, 31 (12): : 37S - 43S
[39] A Real-World Overview of Diabetes Mellitus Profile and Management in Brazil
Chacra, Antonio R.
Franco, Denise R.
Calliari, Luis E. P.
Eliaschewitz, Freddy G.
Ferreira, Graziela
Paula, Mauricio A.
Lima, Leila
Lauand, Felipe
DIABETES, 2017, 66 : A653 - A653
[40] Diagnosis and management of nephropathy in patients with diabetes mellitus
Garber, AJ
Campese, VM
Franz, MJ
Hoogwerf, B
Levy, J
Mitch, W
Moore, MA
Steffes, MW
Bertani, T
Meyer, T
Parving, HH
Mogensen, CE
Adler, S
Lebovitz, H
Walser, M
Keane, W
DIABETES CARE, 1996, 19 : S103 - S106

← 1 2 3 4 5 →